A new market study, titled “Global Cardiology Surgery, Devices and Drugs Market Research and Forecast, 2018-2023”, has been featured on WiseGuyReports.
The report covers three major segments of interventional cardiology market which include surgeries, devices, and drugs. As per WHO more than 17 million people died due to CVD in 2015 which makes is the number one cause of death globally. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China, and Japan. The market of cardiology surgery, devices and drugs are also on a rise.
One of the major factors driving the market is medical tourism. Especially in emerging markets such as India, ASEAN countries and China, the cost of surgery and treatment for cardiovascular diseases is low. In India, a heart surgery costs around $1,500 whereas in the United States it costs 5 to 10 times more than India. Hence, many Americans prefer to travel to India for their treatment.
North America is the leading market with highest market share. The market is expected to grow at a CAGR of 6.8 percent. North American marker is followed by Europe, Asia-Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR of 9.5% for the forecasted period of 2018-2023.
The global cardiology devices & drugs market is expected to grow at a CAGR of 7.4% for the forecasted period of 2018-2023.
Key companies profiled in the report includes Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific Corp., Medtronic, Sun Pharma, Roche Bayer and others.
The Market Segmentation includes:
Cardiology Drugs Market by Indications
Cardiology Drugs Market by Mechanism of Action
The Report Covers:
Comprehensive research methodology of Global cardiology surgery devices drugs market
In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global cardiology surgery devices drugs market.
Insights about market determinants which are stimulating the Global Interventional Cardiology Surgery, Devices and Drugs market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players
Table of Content
CHAPTER 1. REPORT SUMMARY
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
CHAPTER 3. MARKET DETERMINANT
CHAPTER 4. MARKET SEGMENTATION
CHAPTER 5. COMPETITIVE LANDSCAPE
CHAPTER 6. REGIONAL ANALYSIS
CHAPTER 7. COMPANY PROFILES
7.2. SANOFI S.A.
7.5. BRISTOL-MYERS SQUIBB
7.6. 6. MERCK
7.7. BOSTON SCIENTIFIC CORPORATION
7.9. ST. JUDE MEDICAL
7.10. COOK MEDICAL
7.11. CR BARD INC.
7.12. SUN PHARMA
7.13. GE HEALTHCARE
7.14. JOHNSON & JOHNSON
7.15. TAKEDA PHARMACEUTICAL COMPANY LTD
7.16. DAIICHI SANKYO CO. LTD.
7.17. F. HOFFMANN-LA ROCHE LTD
7.18. BAYER AG
7.19. BOEHRINGER INGELHEIM
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)